Xigen

📍 Switzerland🗓 Founded 2002👥 6 employees💰 Last funded 2005
Biotechnology Research🌐 xigenpharma.com
Website LinkedIn
Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2002
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Xigen?
Xigen has 1 investors on record on gritt.io, 1 mid-stage.
When did Xigen last raise funding?
The most recent investment in Xigen recorded on gritt.io was in 2005.
When was Xigen founded?
Xigen was founded in 2002.
What industry is Xigen in?
Xigen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Xigen based?
Xigen is headquartered in Switzerland.